ContributorsMichael Sassano - SOMAÍ Pharmaceuticals

Michael Sassano

CEO
SOMAÍ Pharmaceuticals

Michael Sassano, CEO of SOMAÍ Pharmaceuticals

Michael Sassano was an early investor in the United States cannabis industry and now heads SOMAÍ Pharmaceuticals, a next-generation biotech company centred on the cultivation, manufacturing, and distribution of GMP-certified cannabinoid-containing pharmaceutical products throughout the European Union. SOMAÍ opened Europe’s largest cannabis manufacturing facility earlier this year in Lisbon, Portugal.

Contributor Details
Primary Social Channels

Academic Articles

Contributor's latest research content

Content coming soon. Please check back.

Contributor Profiles

The latest news and updates